Vaccinex, Inc. (VCNX): Shareholders' Equity
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
-$2.49M
As of 2024-12-31
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | -$2.49M | n/m | 2025-04-15, Balance as of period end |
| 2023-12-31 | -$2.31M | n/m | 2025-04-15, Balance as of period end |
| 2022-12-31 | $5.19M | -29.9% | 2024-04-25, Balance as of period end |
| 2021-12-31 | $7.41M | n/m | 2023-03-31, Balance as of period end |
| 2020-12-31 | -$2.61M | n/m | 2022-03-31, Balance as of period end |
| 2019-12-31 | -$2.27M | n/m | 2021-03-31, Balance as of period end |
| 2018-12-31 | $15.34M | n/m | 2020-03-09, Balance as of period end |
| 2017-12-31 | -$113.49M | n/a | 2019-03-13, Balance as of period end |